NYSE:CVS - CVS Health Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $79.59 +0.20 (+0.25 %) (As of 09/21/2018 04:00 PM ET)Previous Close$79.39Today's Range$78.58 - $79.9352-Week Range$60.14 - $83.88Volume12.05 million shsAverage Volume8.29 million shsMarket Capitalization$80.39 billionP/E Ratio13.44Dividend Yield2.53%Beta1.01 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings CVS Health (NYSE:CVS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.17 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $87.5333, suggesting that the stock has a possible upside of 9.98%. The high price target for CVS is $101.00 and the low price target for CVS is $68.00. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.882.882.792.80Ratings Breakdown: 0 Sell Rating(s)4 Hold Rating(s)11 Buy Rating(s)2 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)11 Buy Rating(s)2 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)11 Buy Rating(s)2 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)12 Buy Rating(s)2 Strong Buy Rating(s)Consensus Price Target: $87.5333$86.6667$86.8750$87.5789Price Target Upside: 9.98% upside27.13% upside30.93% upside28.36% upsideCVS Health (NYSE:CVS) Consensus Price Target History CVS Health (NYSE:CVS) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails9/18/2018Royal Bank of CanadaBoost Price TargetOutperform$101.00Medium9/17/2018Bank of AmericaBoost Price TargetBuy$86.00 ➝ $90.00Medium8/9/2018Leerink SwannSet Price TargetOutperform$85.00 ➝ $80.00Low7/9/2018CitigroupReiterated RatingNeutral ➝ Buy$81.00Low7/3/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$88.00 ➝ $80.00Low6/30/2018MizuhoReiterated RatingBuyLow5/7/2018Loop CapitalSet Price TargetHold$68.00Medium2/9/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$85.00 ➝ $80.00Low2/9/2018Needham & Company LLCSet Price TargetStrong-Buy ➝ Buy$100.00 ➝ $98.00Medium1/18/2018CowenReiterated RatingOutperform$81.00 ➝ $99.00Low1/5/2018SunTrust BanksBoost Price TargetBuy$90.00High1/4/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00High1/4/2018UBS GroupUpgradeOutperform ➝ Strong-BuyHigh12/26/2017Tigress FinancialReiterated RatingBuyLow12/5/2017Deutsche BankReiterated RatingBuy ➝ HoldMedium12/4/2017Jefferies Financial GroupSet Price TargetHold$76.00Medium10/9/2017OppenheimerReiterated RatingBuy$95.00N/A8/14/2017Wolfe ResearchDowngradeOutperform ➝ Market Perform$89.00 ➝ $82.00Low7/3/2017GuggenheimReiterated RatingBuyLow5/3/2017Evercore ISIReiterated RatingOutperform$87.00 ➝ $88.00Low2/6/2017Atlantic SecuritiesDowngradeOverweight ➝ Neutral$84.00N/A12/19/2016Credit Suisse GroupReiterated RatingBuyN/A11/10/2016ArgusReiterated RatingBuy$120.00 ➝ $85.00N/A11/9/2016BarclaysReiterated RatingBuy$85.00N/A(Data available from 9/21/2016 forward) This page was last updated on 9/21/2018 by MarketBeat.com StaffFeatured Article: What is a put option?